Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 3/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | GRK2 | P25098 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21609725 | 1.00 | CTDSP1 (0.56) | CTDSP1POLBMAPK1HTTPLCG1 | |
| SCHEMBL22289434 | 0.82 | PLCG1 (0.55) | CTDSP1POLBMAPK1HTTPLCG1 | |
| SCHEMBL11775347 | 0.82 | LMNA (0.50) | CTDSP1MAPK1HTTKMT2AALDH1A1 | |
| SCHEMBL6825855 | 0.81 | ALDH1A1 (0.56) | MAPK1KMT2AALDH1A1NPC1MEN1 | |
| SCHEMBL11774952 | 0.80 | LMNA (0.47) | MAPK1HTTKMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL6624619 | 0.76 | SIGMAR1 (0.57) | POLBMAPK1HTTKMT2AHDAC3 | |
| SCHEMBL2413925 | 0.74 | PLCG1 (0.59) | CTDSP1POLBMAPK1HTTPLCG1 | |
| SCHEMBL7459127 | 0.74 | ALDH1A1 (0.61) | MAPK1KMT2AALDH1A1NPC1RAB9A | |
| SCHEMBL31568130 | 0.74 | POLB (0.57) | POLBKMT2AALDH1A1GAATSHR | |
| SCHEMBL7787695 | 0.73 | KMT2A (0.52) | POLBKMT2AHDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200255457-A1 | PROCESS FOR THE REMOVAL AND RETURN OF A CATALYST TO A LIQUID PHASE MEDIUM | PHOSPHONICS LTD (GB) | 2020-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200255457-A1 | PROCESS FOR THE REMOVAL AND RETURN OF A CATALYST TO A LIQUID PHASE MEDIUM | MSR1, NOC2L, GFRA2 | CTDSP1 515/4885POLB 776/4885MAPK1 3846/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.